BX Swiss TOP 30 CHF
1.386,27
PKT
+7,48
PKT
+0,54
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 19.06.12 | Julius Bär buy | Sarasin Research | |
| 19.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.06.12 | Julius Bär hold | Vontobel Research | |
| 18.06.12 | Holcim buy | UBS AG | |
| 18.06.12 | ABB (Asea Brown Boveri) neutral | J.P. Morgan Cazenove | |
| 18.06.12 | Nestlé hold | Vontobel Research | |
| 15.06.12 | Holcim hold | Deutsche Bank AG | |
| 15.06.12 | Holcim hold | Deutsche Bank AG | |
| 15.06.12 | ABB (Asea Brown Boveri) neutral | UBS AG | |
| 15.06.12 | UBS neutral | Sarasin Research | |
| 15.06.12 | UBS neutral | Sarasin Research | |
| 15.06.12 | UBS halten | Independent Research GmbH | |
| 15.06.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 14.06.12 | ABB (Asea Brown Boveri) hold | Deutsche Bank AG | |
| 14.06.12 | Holcim overweight | Morgan Stanley | |
| 14.06.12 | Holcim buy | ING | |
| 14.06.12 | Swisscom neutral | Sarasin Research | |
| 14.06.12 | Holcim outperform | Cheuvreux SA | |
| 14.06.12 | Straumann underperform | Cheuvreux SA | |
| 14.06.12 | Holcim outperform | Cheuvreux SA | |
| 14.06.12 | Holcim hold | Vontobel Research | |
| 13.06.12 | UBS outperform | Credit Suisse Group | |
| 13.06.12 | Roche buy | Goldman Sachs Group Inc. | |
| 13.06.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 13.06.12 | Zurich Insurance buy | Vontobel Research | |
| 13.06.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 13.06.12 | Swiss Re buy | Vontobel Research | |
| 12.06.12 | UBS neutral | UBS AG | |
| 12.06.12 | Julius Bär buy | UBS AG | |
| 12.06.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 12.06.12 | Swiss Life buy | Nomura | |
| 12.06.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 11.06.12 | Nestlé hold | Société Générale Group S.A. (SG) | |
| 11.06.12 | UBS hold | Commerzbank Corp. & Markets | |
| 11.06.12 | Roche neutral | J.P. Morgan Cazenove | |
| 11.06.12 | Roche neutral | Nomura | |
| 11.06.12 | Novartis hold | Vontobel Research | |
| 08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 08.06.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. |